{"id":"https://openalex.org/W2462685573","doi":"https://doi.org/10.1182/blood.v126.23.4869.4869","title":"Early Allogeneic Stem Cell Transplantation and Use of Asparaginase during Induction Chemotherapy Appear to Improve Otherwise Poor Outcomes in Adult T-Cell Acute Lymphoblastic Leukemia/Lymphoma (T-ALL/T-LBL) Patients: A Multi-Institutional Review","display_name":"Early Allogeneic Stem Cell Transplantation and Use of Asparaginase during Induction Chemotherapy Appear to Improve Otherwise Poor Outcomes in Adult T-Cell Acute Lymphoblastic Leukemia/Lymphoma (T-ALL/T-LBL) Patients: A Multi-Institutional Review","publication_year":2015,"publication_date":"2015-12-03","ids":{"openalex":"https://openalex.org/W2462685573","doi":"https://doi.org/10.1182/blood.v126.23.4869.4869","mag":"2462685573"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v126.23.4869.4869","doi":"https://doi.org/10.1182/blood.v126.23.4869.4869","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.4869.4869","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013231204","display_name":"Uma Borate","orcid":"https://orcid.org/0000-0002-4958-4962","observed_orcids":["https://orcid.org/0000-0002-4958-4962"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Uma Borate","raw_affiliation_strings":["University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010040145","display_name":"Amanda Redden Hathaway","orcid":"https://orcid.org/0009-0006-5025-5206","observed_orcids":["https://orcid.org/0009-0006-5025-5206"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amanda Redden Hathaway","raw_affiliation_strings":["University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044434582","display_name":"Deniz Peker","orcid":"https://orcid.org/0000-0002-4327-2861","observed_orcids":["https://orcid.org/0000-0002-4327-2861"]},"institutions":[{"id":"https://openalex.org/I17301866","display_name":"University of Alabama","ror":"https://ror.org/03xrrjk67","country_code":"US","type":"education","lineage":["https://openalex.org/I17301866"]},{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Deniz Peker","raw_affiliation_strings":["Pathology, University of Alabama-Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pathology, University of Alabama-Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I17301866","https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074244901","display_name":"Bradford E. Jackson","orcid":"https://orcid.org/0000-0003-0950-2907","observed_orcids":["https://orcid.org/0000-0003-0950-2907"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bradford E Jackson","raw_affiliation_strings":["University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062561099","display_name":"Vamsi K Kota","orcid":"https://orcid.org/0000-0002-5290-9289","observed_orcids":["https://orcid.org/0000-0002-5290-9289"]},"institutions":[{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vamsi K Kota","raw_affiliation_strings":["Winship Cancer Institute of Emory University, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Winship Cancer Institute of Emory University, Atlanta, GA","institution_ids":["https://openalex.org/I4390039307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025137989","display_name":"Bijal Dinesh Shah","orcid":"https://orcid.org/0000-0003-4328-6021","observed_orcids":["https://orcid.org/0000-0003-4328-6021"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bijal D Shah","raw_affiliation_strings":["H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038765418","display_name":"Ling Zhang","orcid":"https://orcid.org/0000-0001-8371-5252","observed_orcids":["https://orcid.org/0000-0001-8371-5252"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ling Zhang","raw_affiliation_strings":["Department of Hematopathology and Laboratory Medicine, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematopathology and Laboratory Medicine, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034221305","display_name":"Anand Jillella","orcid":"https://orcid.org/0000-0002-6279-7567","observed_orcids":["https://orcid.org/0000-0002-6279-7567"]},"institutions":[{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anand Jillella","raw_affiliation_strings":["Winship Cancer Institute of Emory University, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Winship Cancer Institute of Emory University, Atlanta, GA","institution_ids":["https://openalex.org/I4390039307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014892222","display_name":"Martha Lucia Arellano","orcid":"https://orcid.org/0000-0003-1636-1962","observed_orcids":["https://orcid.org/0000-0003-1636-1962"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martha Arellano","raw_affiliation_strings":["Emory University Sch. of Med., Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory University Sch. of Med., Atlanta, GA","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064293376","display_name":"Leonard T. Heffner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leonard T. Heffner","raw_affiliation_strings":["Winship Cancer Institute, Emory University, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Winship Cancer Institute, Emory University, Atlanta, GA","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4390039307"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5050556099","display_name":"Harry Paul Erba","orcid":"https://orcid.org/0000-0003-1093-2189","observed_orcids":["https://orcid.org/0000-0003-1093-2189"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Harry P Erba","raw_affiliation_strings":["Division of Hematology and Oncology, University of Alabama, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, University of Alabama, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.3569,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.72052812,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"126","issue":"23","first_page":"4869","last_page":"4869"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adult-t-cell-acute-lymphoblastic-leukemia","display_name":"adult T-cell acute lymphoblastic leukemia","score":0.8980000019073486},{"id":"https://openalex.org/keywords/t-lymphoblastic-lymphoma","display_name":"T-cell lymphoblastic lymphoma","score":0.906000018119812},{"id":"https://openalex.org/keywords/allogeneic-stem-cell-transplantation","display_name":"allogeneic stem cell transplantation","score":0.9369999766349792},{"id":"https://openalex.org/keywords/l-asparaginase","display_name":"L-asparaginase","score":0.9649999737739563},{"id":"https://openalex.org/keywords/induction-chemotherapy","display_name":"induction chemotherapy","score":0.9829999804496765},{"id":"https://openalex.org/keywords/relapse-free-survival","display_name":"relapse-free survival","score":0.8420000076293945},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9980000257492065},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8500000238418579},{"id":"https://openalex.org/keywords/prognostic-score","display_name":"prognostic score","score":0.4620000123977661},{"id":"https://openalex.org/keywords/prognostic-score-2","display_name":"prognostic score 2","score":0.34599998593330383},{"id":"https://openalex.org/keywords/prognostic-score-3","display_name":"prognostic score 3","score":0.7820000052452087},{"id":"https://openalex.org/keywords/prognostic-score-4","display_name":"prognostic score 4","score":0.7549999952316284},{"id":"https://openalex.org/keywords/prognostic-score-5","display_name":"prognostic score 5","score":0.718999981880188}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8020812273025513},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.5760471224784851},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5630100965499878},{"id":"https://openalex.org/C144301174","wikidata":"https://www.wikidata.org/wiki/Q7893852","display_name":"Univariate analysis","level":3,"score":0.5392535924911499},{"id":"https://openalex.org/C2777478502","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Lymphoblastic lymphoma","level":4,"score":0.5265583992004395},{"id":"https://openalex.org/C119060515","wikidata":"https://www.wikidata.org/wiki/Q1916617","display_name":"Interquartile range","level":2,"score":0.5035781264305115},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.4679839611053467},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.45511889457702637},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.44954320788383484},{"id":"https://openalex.org/C2781107101","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Acute lymphocytic leukemia","level":4,"score":0.44423606991767883},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.41266191005706787},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3616650402545929},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.32776033878326416},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.2854525148868561},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.24724122881889343},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.22106415033340454},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.19472944736480713},{"id":"https://openalex.org/C2909962599","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Lymphoblastic Leukemia","level":3,"score":0.1372162401676178},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v126.23.4869.4869","doi":"https://doi.org/10.1182/blood.v126.23.4869.4869","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.4869.4869","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2419311212","https://openalex.org/W4310104762","https://openalex.org/W3144351214","https://openalex.org/W2592382729","https://openalex.org/W4389258969","https://openalex.org/W4404447066","https://openalex.org/W4399760219","https://openalex.org/W2585589059","https://openalex.org/W2335504484","https://openalex.org/W2555070547"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"AdultT-cell":[2],"acute":[3],"lymphoblastic":[4],"leukemia/lymphoma":[5],"(T-ALL/T-LBL)":[6],"is":[7,605],"a":[8,15,32,100,239,244,378,390,541,546,573],"rare,":[9],"aggressive":[10],"bone":[11,69],"marrow":[12,70],"malignancy":[13],"with":[14,116,217,222,231,265,326,377,400,515],"historically":[16],"poor":[17,574],"prognosis":[18],"despite":[19],"use":[20,489,591],"of":[21,34,92,103,111,184,189,205,219,227,234,354,439,442,472,522,552,611,681,710,733],"various":[22],"chemotherapies.":[23],"Methods:":[24],"After":[25,276],"institutional":[26],"review":[27,579],"board":[28],"approval,":[29],"we":[30,108],"compiled":[31],"database":[33],"all":[35],"adult":[36,173,570,640],"T-ALL/T-LBL":[37,571],"cases":[38],"at":[39,49,63,87,177,259,386],"three":[40],"large":[41],"cancer":[42],"centers":[43],"between":[44],"the":[45,50,104,112,148,157,207,272,361,404,437,440,470,519,530],"years":[46],"2005-2015,":[47],"treated":[48,221,237],"physician's":[51],"discretion.":[52],"Data":[53,768],"collected":[54],"included":[55,171],"patient":[56,75],"demographics,":[57],"tumor":[58],"characteristics":[59],"(white":[60],"cell":[61],"count":[62,382],"diagnosis,":[64],"blast":[65],"phenotype,":[66],"FISH,":[67],"cytogenetics,":[68],"involvement),":[71],"treatment":[72,213,263,274,418],"regimens":[73,214],"and":[74,80,89,126,133,138,156,165,202,247,305,369,429,445,583,596,616],"outcomes.":[76,650],"Relapse-free":[77],"survival":[78,82,105,154,161,493,517],"(RFS)":[79],"overall":[81,463],"(OS)":[83],"were":[84,186,191,194,197,200,215,236],"examined":[85,615],"looking":[86],"medians":[88],"interquartile":[90],"ranges":[91],"times":[93],"to":[94,130,151,159,324,397,491,526,646],"events.":[95],"Kaplan":[96],"Meier":[97],"curves":[98],"provided":[99,109],"graphical":[101],"representation":[102],"probability.":[106],"Moreover,":[107],"estimates":[110],"50th":[113],"percentile":[114],"along":[115],"corresponding":[117],"95%":[118,140],"confidence":[119],"intervals":[120],"(CIs).":[121],"We":[122],"also":[123,145],"used":[124,216],"Univariate":[125],"Multivariable":[127],"Cox":[128],"Regression":[129],"estimate":[131],"unadjusted":[132],"adjusted":[134],"Hazard":[135],"Ratios":[136],"(HRs)":[137],"their":[139,416,649],"CIs.":[141],"Stratified":[142],"analysis":[143,170],"was":[144,179,209,366,372,389,467,613],"performed":[146],"using":[147,643],"Mann-Whitney":[149],"U-test":[150],"compare":[152,160],"median":[153,364,370,516],"times,":[155],"Log-rank":[158],"curses":[162],"for":[163,436,693],"RFS":[164,365,423,457,551,584],"OS.":[166],"Results:":[167],"The":[168],"final":[169],"95":[172],"patients.":[174],"Median":[175],"age":[176],"diagnosis":[178],"32":[180],"(range":[181],"17-75).":[182],"71.6%":[183],"patients":[185,190,206,220,228,235,255,267,280,285,310,321,335,345,357,376,398,447,475,484,506,532,599,620,642],"male.":[187],"49.5%":[188],"white,":[192],"14.7%":[193],"black,":[195],"6.3%":[196,248],"Hispanic,":[198],"7.4%":[199],"Asian":[201],"in":[203,271,314,403,415,456,469,474,483,513,518,529,543,550,560,592,600,607,638],"22.1%":[204],"race":[208],"unknown.":[210],"Multiple":[211],"frontline":[212],"60%":[218],"Hyper-CVAD,":[223],"an":[224,511,678,707,730],"additional":[225],"5.3%":[226],"received":[229,249,257,413,449,540,625],"Hyper-CVAD":[230],"asparaginase,":[232],"24.2%":[233],"on":[238,243,677,706,729],"pediatric-based":[240],"protocol,":[241],"4.2%":[242],"clinical":[245],"trial,":[246],"other":[250],"regimens.":[251],"In":[252,360,375,462],"total,":[253],"40":[254,477,622],"(42.1%)":[256],"asparaginase":[258,414,451,473,488,590,612,626],"some":[260],"point":[261],"during":[262],"regimen":[264,419],"27":[266,523],"(28.4%)":[268],"receiving":[269],"it":[270],"initial":[273,417,450],"regimen.":[275],"induction":[277],"therapy,":[278,333],"65":[279],"(68.4%)":[281],"achieved":[282],"remission.":[283],"Twenty-eight":[284],"(29.5%)":[286],"underwent":[287,312,347,508],"transplant":[288,313,325,348,509,520,542],"(8":[289],"matched-related":[290],"donors,":[291,295],"10":[292],"matched":[293],"unrelated":[294,298],"5":[296],"mismatched":[297],"donor,":[299],"2":[300,303],"cord":[301],"transplants,":[302],"autologous,":[304],"1":[306],"haplo-identical":[307],"transplant).":[308],"Ten":[309],"(10.5%)":[311],"first":[315,601],"complete":[316],"remission":[317],"(CR1)":[318],"while":[319],"two":[320],"(2.1%)":[322],"proceeded":[323],"minimal":[327],"residual":[328],"disease":[329,339,350],"following":[330],"induction.":[331],"Despite":[332],"59":[334],"(62.1%)":[336],"had":[337,453,510,545],"known":[338],"relapse":[340,394],"or":[341,629,683,712,735],"progressive":[342],"disease.":[343],"16":[344],"(16.8%)":[346],"after":[349],"relapse.":[351],"At":[352],"time":[353],"analysis,":[355],"57":[356],"(60.6%)":[358],"died.":[359],"entire":[362],"cohort,":[363],"12.9":[367],"months":[368,524,528,554,556,559],"OS":[371,430,582],"19":[373],"months.":[374],"very":[379],"high":[380],"white":[381,401],"(>100":[383],"x":[384],"103/cmm":[385],"presentation)":[387],"there":[388],"trend":[391,547],"toward":[392],"earlier":[393],"when":[395],"compared":[396,525],"presenting":[399],"counts":[402],"normal":[405],"range":[406],"(HR":[407,424,431,458,478,494],"2.27,":[408],"p-value":[409,426,460,535,565],"0.085).":[410],"Patients":[411,538],"who":[412,448,507,539],"have":[420],"statistically":[421],"improved":[422,587],"2.65,":[425],"=":[427,536,566],"0.014)":[428],"2.3,":[432],"p-value=0.017).":[433],"When":[434],"adjusting":[435],"presence":[438],"covariates":[441],"age,":[443],"sex,":[444],"WBC,":[446],"still":[452],"significant":[454,465],"improvement":[455,512,549],"3.18,":[459],"0.033).":[461],"survival,":[464],"benefit":[466],"seen":[468],"addition":[471],"under":[476],"3.4,":[479],"CI":[480,496],"1.22-9.5),":[481],"however":[482],"greater":[485],"than":[486],"40,":[487],"seemed":[490],"decrease":[492],"0.24,":[495],"0.03-1),":[497],"although":[498],"this":[499],"did":[500],"not":[501,614],"reach":[502],"statistical":[503],"significance.":[504],"All":[505],"OS,":[514],"group":[521],"18.2":[527],"non-transplanted":[531,561],"(log-rank":[533],"test":[534,564],"0.048).":[537],"CR1":[544],"towards":[548],"6.3":[553],"(17.8":[555],"versus":[557],"11.5":[558],"patients;":[562],"log-rank":[563],"0.03).":[567],"Conclusion:":[568],"Overall,":[569],"has":[572],"prognosis.":[575],"Our":[576,603],"multi-institutional":[577],"retrospective":[578],"showed":[580],"that":[581,608,617],"may":[585],"be":[586],"by":[588,597],"incorporating":[589],"front":[593],"line":[594],"therapy":[595],"transplanting":[598],"CR.":[602],"data":[604],"limited":[606],"actual":[609],"dosing":[610],"relatively":[618],"few":[619],">":[621],"yrs":[623],"old":[624],"(4":[627],"pts)":[628],"SCT":[630],"(5":[631],"pts).":[632],"More":[633],"prospective":[634],"studies":[635],"are":[636],"needed":[637],"older":[639],"T-ALL/LBL":[641],"these":[644],"approaches":[645],"possibly":[647],"improve":[648],"Disclosures":[651],"Borate:":[652],"Gilead:":[653],"Speakers":[654,663,666,669,719,722,738,741],"Bureau;":[655,664,667,720,723,739,742],"Genoptix:":[656],"Consultancy;":[657,748],"Seattle":[658,743,773],"Genetics:":[659,744],"Research":[660,673,689,696,700,745,754,777,782],"Funding;":[661,697,701,746,778,783],"Novartis:":[662],"Amgen:":[665,775],"Alexion:":[668],"Bureau.":[670],"Hathaway:OnQ":[671],"Health:":[672],"Funding.":[674,690,755],"Kota:Pfizer:":[675],"Membership":[676,705,728],"entity's":[679,708,731],"Board":[680,709,732],"Directors":[682,711,734],"advisory":[684,713,736],"committees;":[685,714],"Leukemia":[686],"Lymphoma":[687,752],"Society:":[688,753],"Shah:DeBartolo":[691],"Institute":[692],"Personlaized":[694],"Medicine:":[695],"Rosetta":[698],"Genomics:":[699],"Acetylon":[702],"Pharmaceuticals,":[703],"INC:":[704],"Plexus":[715],"Communications:":[716],"Honoraria;":[717,725],"Pharmacyclics:":[718],"Spectrum:":[721],"Bayer:":[724],"Celgene:":[726,760],"Consultancy,":[727,761,776],"committees,":[737],"Janssen:":[740,766],"SWOG:":[747],"NCCN:":[749],"Consultancy.":[750,757,788],"Jillella:Leukemia":[751],"Heffner:Amgen:":[756],"Erba:Novartis;":[758],"Incyte;":[759],"Patents":[762],"&":[763,770],"Royalties;":[764],"GlycoMimetics;":[765],"Other:":[767],"Safety":[769],"Monitoring":[771],"Committees;":[772],"Genetics;":[774],"Millennium/Takeda;":[779],"Celator;":[780],"Astellas:":[781],"Sunesis;Pfizer;":[784],"Daiichi":[785],"Sankyo;":[786],"Ariad:":[787]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2016-07-22T00:00:00"}